Indolent prostate cancer and active surveillance Sue Mayor 1 January 2010 Grandround 0 Number 34 Download pdf article Early aggressive treatment in patients whose cancer is likely to progress slowly, if at all, causes side-effects and reduces their quality of life for no benefit. Can active surveillance avoid this? Download full article active surveillanceprostate cancer
Cutting Edge Don’t shoot the driver! It’s about taxonomy more than targets Cutting Edge, Featured 9 March 2018 0
News Metastatic prostate cancer: cabazitaxel shows quality of life benefits over both abiraterone and enzalutamide News 6 October 2020 0
